NCT00115518View on ClinicalTrials.gov

Radiation Plus Cetuximab in Locally Advanced Non-Small Cell Lung Cancer (NSCLC)

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

May 31, 2005

Primary Completion Date

June 30, 2009

Study Completion Date

August 31, 2010

Conditions
Carcinoma, Non-Small-Cell Lung
Interventions
DRUG

cetuximab

After Cetuximab loading dose. weekly cetuximab during RT. 13 weeks cetuximab weekly maintenance

Trial Locations (1)

69120

University of Heidelberg, Heidelberg

All Listed Sponsors
lead

Heidelberg University

OTHER

NCT00115518 - Radiation Plus Cetuximab in Locally Advanced Non-Small Cell Lung Cancer (NSCLC) | Biotech Hunter | Biotech Hunter